Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9599 posts found.

Crisis in the boardroom: 2011’s most dramatic departures

January 11, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Actelion, KV pharmaceuticals, Kindler, Pfizer, management

In December 2010, Jeffrey Kindler, the chief executive of Pfizer suddenly announced his departure from the company.His abrupt exit made …
Feature

Janssen signs deal with rising star Forma

January 11, 2012 Research and Development Forma, Janssen, alliance

Janssen has signed a deal with Forma Therapeutics to discover, and develop drugs that target tumour metabolism mechanisms.Forma focuses on …
News

Richard Barker joins Aegate as a senior advisor

January 11, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Aegate, Richard Barker

Aegate’s board of directors have announced that the previous director general of the ABPI has joined the company as a …
Appointment
Sanofi picture

Sanofi to collaborate with UCSF on diabetes research

January 11, 2012 Research and Development RNA interference, Sanofi, UCSF, academic alliance, diabetes

The University of California, San Francisco (UCSF) and Sanofi are to launch a new collaboration in diabetes research, focusing on …
News

Underwhelming results for GSK’s Relovair

January 10, 2012 Research and Development, Sales and Marketing Advair, COPD, GSK, Relovair, Seretide, asthma

GlaxoSmithKline says it is on track to file its respiratory drug Relovair in Europe and the US despite mixed results …
News

Shire signs strategic partnership deal with ICON

January 10, 2012 Research and Development ICON, Shire

Contract research organisation ICON has signed a strategic partnership with Shire Specialty Pharmaceuticals to be the sole global provider of …
News

Study supports GLP-1 agonists for weight loss

January 10, 2012 Research and Development, Sales and Marketing GLP-1, Novo Nordisk, Sanofi, diabetes, lilly

An independent study by academics has concluded that GLP-1 agonist drugs help patients to lose weight – with the effect …
News

BMS to buy hep C firm Inhibitex for $2.5 billion

January 9, 2012 Research and Development, Sales and Marketing BMS, Inhibitex, hep C

Bristol-Myers Squibb will acquire virology specialist Inhibitex for $2.5 billion, expanding its infectious disease portfolio. Bristol-Myers Squibb will acquire the …
News

Celgene appoints Dr David Gillen as its UK and Ireland medical director

January 9, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Celgene

Celgene has appointed former Pfizer man Dr David Gillen as its new UK and Ireland medical director. Gillen brings much …
Appointment
Merkel and Sarkozy

2011 Year In Review

January 6, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing 2011, Europe, emerging markets, year in review

A round up of some of the key themes in pharma’s yearEUROPE IN CRISIS While the Eurozone has averted meltdown …
Feature

New requirements for the technical validations of Marketing Authorisation Applications

January 6, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

The current EU- eCTD v3.1 validation criteria came into force on 1st September 2011 for the technical validation for all …
News
Press release

GSK faces fine over Argentina clinical trial

January 6, 2012 Research and Development, Sales and Marketing Argentina, GSK, Vaccine, deaths, emerging markets

A court in Argentina says GSK should be fined for irregularities in recruitment during a trial in which children died. …
News

Biogen inks $299m deal for rare genetic disorder drug

January 5, 2012 Research and Development, Sales and Marketing Biogen, Isis Pharma

Biogen has signed a new deal with drug discovery firm Isis for its spinal muscular atrophy drug ISIS-SMNRx. Biogen will pay …
News

AstraZeneca to take Alzheimer’s drug into phase II

January 5, 2012 Research and Development Alzheimer's, AstraZeneca, Targacept

AstraZeneca is to continue the development of Targacept’s AZD1446 as a treatment for Alzheimer’s disease.AZD1446 is a selective modulator of …
News

Orphan status for haemophilia gene therapy

January 4, 2012 Research and Development AMT, gene therapy, haemophilia

Amsterdam Molecular Therapeutics has been granted an orphan drug designation for its gene therapy for haemophilia B.The FDA’s orphan designation …
News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026